Similarly, while the impact of FLT3 mutations has been widely explored in acute myeloid leukemia [40], it is unclear whether FLT3 mutations affect the outcome of ALL patients [26, 30, 31]. This evidence concerns the gene FLT3 and acute myeloid leukemia.